The present invention is directed to cinnoline derivatives pharmaceutical compositions containing them and their use in the treatment of disorders and conditions mediated by the CB-1 receptor; more particularly, use in the treatment of disorders and conditions responsive to inverse agonism of the CB-1 receptor. More particularly, the compounds of the present invention are useful in the treatment of metabolic disorders.
本发明涉及
喹啉衍
生物药物组合物,包含它们以及它们在治疗由CB-1受体介导的疾病和病状中的应用;更具体地,用于治疗对CB-1受体的反向激动作用有响应的疾病和病状的应用。更具体地,本发明的化合物在代谢性疾病的治疗中是有用的。